Insider Transactions

Insider Transactions
Date Name Title Type Shares Traded Price Range
Oct 18, 2017 crowley john f Officer Automatic Sell 19,013 14.76
Oct 18, 2017 crowley john f Officer Option Execute 19,013 14.76
Oct 17, 2017 crowley john f Officer Automatic Sell 52,722 14.75
Oct 17, 2017 crowley john f Officer Option Execute 52,722 14.75
Oct 16, 2017 crowley john f Officer Automatic Sell 47,135 14.75
Oct 16, 2017 crowley john f Officer Option Execute 47,135 14.75
Oct 13, 2017 crowley john f Officer Automatic Sell 22,160 14.75
Oct 13, 2017 crowley john f Officer Option Execute 22,160 14.75
Oct 12, 2017 baird william d iii Officer Automatic Sell 40,000 14.25
Oct 12, 2017 baird william d iii Officer Option Execute 40,000 14.25
Oct 12, 2017 barth jay Officer Automatic Sell 5,000 14.25
Oct 12, 2017 barth jay Officer Option Execute 5,000 14.25
Oct 12, 2017 crowley john f Officer Automatic Sell 380,000 14.25
Oct 12, 2017 crowley john f Officer Option Execute 380,000 14.25
Oct 12, 2017 do hung Officer Automatic Sell 50,194 14.25
Oct 12, 2017 do hung Officer Option Execute 50,194 14.25
Oct 12, 2017 quimi daphne Officer Automatic Sell 7,000 14.25
Oct 12, 2017 quimi daphne Officer Option Execute 7,000 14.25
Oct 12, 2017 raab michael Director Automatic Sell 10,000 14.25
Oct 12, 2017 raab michael Director Option Execute 10,000 14.25
Sep 26, 2017 crowley john f Officer Buy 1,395 14.36
Jul 13, 2017 perceptive advisors llc Beneficial Owner (10% or more) Buy 1,500,000 12.25
Jun 19, 2017 barth jay Officer Automatic Sell 30,000 10.00
Jun 19, 2017 barth jay Officer Option Execute 30,000 10.00
Jun 15, 2017 baird william d iii Officer Disposition (Non Open Market) 1,554 8.79
Page:
1
... NextLast

Stock transaction information provided by EDGAR Online. Amicus Therapeutics makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.